7 insights from Providence’s chief of virtual care

The latest stories trending on MedCity News.

Editor's Pick

Top Story 7 Takeaways From a Fireside Chat with Providence's Chief of Virtual Care Dr. Cunningham weighed in on a variety of subjects, including elements of technology and virtual care that burden primary care physicians, as well as technologies that are suitable for remote monitoring of older patients. Sponsored Best Practices in Achieving Revenue Cycle Excellence Presented by Greenway Health Discover the best practices in revenue cycle management to enhance financial health and streamline administrative processes in healthcare.  Learn More.

Featured News

3 Questions VCs Ask When Getting Pitched By Startups During a panel discussion at MedCity News' INVEST Digital Health conference in Dallas, three venture capital investors shared some of the questions they ask when getting pitched by digital health startups. 32BJ Labor Industry Cooperation Fund Launches New Tools to Reduce Costs for Employers The 32BJ Labor Industry Cooperation Fund recently unveiled two new tools for employers and unions: the Healthcare Savings Calculator and a model contract template. 7 Takeaways From a Fireside Chat with Providence's Chief of Virtual Care Dr. Cunningham weighed in on a variety of subjects, including elements of technology and virtual care that burden primary care physicians, as well as technologies that are suitable for remote monitoring of older patients. Breaking Barriers: Why Accessibility Matters in PTSD Treatment Beyond MDMA MDMA-assisted therapy (MDMA-AT) for PTSD sparked debate, primarily focused on concerns of safety and efficacy. But no matter how novel a treatment may be, if it is inaccessible to the millions of people who need it, its relevance becomes insignificant.  Navigating the Government's Medicare Advantage Prior Authorization Changes The reintroduction of the "Improving Seniors' Timely Access to Care Act" marks a critical step toward modernizing the prior authorization process within Medicare Advantage plans. So, what does this mean for patients and providers moving forward? AI-Designed Insilico Drug Flashes Signs of Efficacy in Lung Disease, But Rivals Are Still Ahead Insilico Medicine's idiopathic pulmonary fibrosis drug led to dose-dependent improvement in lung function in a mid-stage study. Meanwhile, Pliant Therapeutics and PureTech Health are also making Phase 2 progress while Boehringer Ingelheim is planning regulatory submission supported by its IPF drug's Phase 3 data.

Resources

Debunked | No-Fluff Healthcare News Show | Presented by MedCity News | Episode 8 In this episode, we address a judge's ruling against FTC's ban on non-compete clauses in employment contracts and its implications for healthcare workers. Also, Pfizer's launch of a digital platform providing easy access to providers and medications for migraine patients and vaccine seekers. Finally, Johnson & Johnson's attempt to modify its 340B drug discount program, which offers reduced prices on outpatient medications to hospitals serving uninsured patients. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe